Relationship between serum fibroblast growth factor-23 level and mortality in chronic hemodialysis patients.

Item

http://www.wikidata.org/entity/Q45030154

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Relationship between serum fib ...... chronic hemodialysis patients.

@en

Relationship between serum fib ...... chronic hemodialysis patients.

@nl

type

Item

label

Relationship between serum fib ...... chronic hemodialysis patients.

@en

Relationship between serum fib ...... chronic hemodialysis patients.

@nl

prefLabel

Relationship between serum fib ...... chronic hemodialysis patients.

@en

Relationship between serum fib ...... chronic hemodialysis patients.

@nl

P1476

Relationship between serum fib ...... chronic hemodialysis patients.

@en

P2093

Himiko Sugimoto

http://www.w3.org/2001/XMLSchema#string

Kosaku Nitta

http://www.w3.org/2001/XMLSchema#string

Kuniaki Otsuka

http://www.w3.org/2001/XMLSchema#string

Tetsuya Ogawa

http://www.w3.org/2001/XMLSchema#string

Yuko Iwabuchi

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain

Fibroblast growth factor (FGF)-23 inhibits renal phosphate reabsorption by activation of the mitogen-activated protein kinase pathway

Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers.

Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease.

Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population.

FGF23 induces left ventricular hypertrophy

Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem.

Investigation of gender heterogeneity in the associations of serum phosphorus with incident coronary artery disease and all-cause mortality.

P304

99-106

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11255-013-0386-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23355029

http://www.w3.org/2001/XMLSchema#string